'Steady Bullish' Options Activity in Pfizer (PFE) Ahead of Q4 Earnings Announcement on Jan. 30th -Susquehanna
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.45 -1.25%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.9%
EPS Growth %: -12.6%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes "steady bullish" options activity in Pfizer (NYSE: PFE) ahead of fourth quarter earnings on Jan. 30th, as investors purchased ~20,000 Feb 38 Calls and 10,000 Feb 38.5 Calls.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Upgrades Whitehaven Coal Ltd. (WHC:AU) (WHITF) to Overweight
- Dell’s earning report was bullish for Intel CPU demand, analyst says
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of Companies, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
